Compare IBEX & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBEX | ZVRA |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 472.9M |
| IPO Year | 2017 | 2015 |
| Metric | IBEX | ZVRA |
|---|---|---|
| Price | $28.46 | $9.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $35.00 | $23.00 |
| AVG Volume (30 Days) | 109.2K | ★ 769.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.26 | ★ 159.21 |
| EPS | ★ 1.65 | 1.35 |
| Revenue | ★ $558,273,000.00 | $106,470,000.00 |
| Revenue This Year | $14.13 | $37.27 |
| Revenue Next Year | $5.68 | $53.42 |
| P/E Ratio | $17.25 | ★ $7.20 |
| Revenue Growth | 9.77 | ★ 350.91 |
| 52 Week Low | $22.63 | $6.77 |
| 52 Week High | $42.99 | $13.16 |
| Indicator | IBEX | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 55.71 |
| Support Level | $28.26 | $8.29 |
| Resistance Level | $30.55 | $10.15 |
| Average True Range (ATR) | 0.87 | 0.38 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 85.33 | 78.63 |
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.